Brant Skanson, RPh speaks on Compounding Pharmacies and the Law at the 16th annual A4M conference in Las Vegas, Nevada. More: Given the present climate of uncertainty for compounding pharmacies, patients, and prescribing physicians, we establish the charge of the US Food & Drug Administration (FDA), and review the history of its attempts to regulate compounding. Provides the latest update on the state of Bioidentical Hormone Replacement (specifically Estriol) as it relates to the FDA.
Item #A4M083WSS1-04
Link to this comment:
All Comments (1)